Correlation Between Tff Pharmaceuticals and Mineralys Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Tff Pharmaceuticals and Mineralys Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tff Pharmaceuticals and Mineralys Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tff Pharmaceuticals and Mineralys Therapeutics, Common, you can compare the effects of market volatilities on Tff Pharmaceuticals and Mineralys Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tff Pharmaceuticals with a short position of Mineralys Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tff Pharmaceuticals and Mineralys Therapeutics,.
Diversification Opportunities for Tff Pharmaceuticals and Mineralys Therapeutics,
0.17 | Correlation Coefficient |
Average diversification
The 3 months correlation between Tff and Mineralys is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding Tff Pharmaceuticals and Mineralys Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mineralys Therapeutics, and Tff Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tff Pharmaceuticals are associated (or correlated) with Mineralys Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mineralys Therapeutics, has no effect on the direction of Tff Pharmaceuticals i.e., Tff Pharmaceuticals and Mineralys Therapeutics, go up and down completely randomly.
Pair Corralation between Tff Pharmaceuticals and Mineralys Therapeutics,
Given the investment horizon of 90 days Tff Pharmaceuticals is expected to under-perform the Mineralys Therapeutics,. In addition to that, Tff Pharmaceuticals is 1.98 times more volatile than Mineralys Therapeutics, Common. It trades about -0.08 of its total potential returns per unit of risk. Mineralys Therapeutics, Common is currently generating about 0.0 per unit of volatility. If you would invest 1,674 in Mineralys Therapeutics, Common on August 31, 2024 and sell it today you would lose (363.00) from holding Mineralys Therapeutics, Common or give up 21.68% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Tff Pharmaceuticals vs. Mineralys Therapeutics, Common
Performance |
Timeline |
Tff Pharmaceuticals |
Mineralys Therapeutics, |
Tff Pharmaceuticals and Mineralys Therapeutics, Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Tff Pharmaceuticals and Mineralys Therapeutics,
The main advantage of trading using opposite Tff Pharmaceuticals and Mineralys Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tff Pharmaceuticals position performs unexpectedly, Mineralys Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mineralys Therapeutics, will offset losses from the drop in Mineralys Therapeutics,'s long position.Tff Pharmaceuticals vs. Cue Biopharma | Tff Pharmaceuticals vs. Eliem Therapeutics | Tff Pharmaceuticals vs. Inhibrx | Tff Pharmaceuticals vs. Enliven Therapeutics |
Mineralys Therapeutics, vs. Cue Biopharma | Mineralys Therapeutics, vs. Tff Pharmaceuticals | Mineralys Therapeutics, vs. Eliem Therapeutics | Mineralys Therapeutics, vs. Inhibrx |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Complementary Tools
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |